Moderna, Inc. (MRNA) — Free Cash Flow Yield
Healthcare
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
| Metric | Value |
|---|---|
| FCF Yield | -8.2% |
| Healthcare Sector Avg FCF Yield | 4.9% |
| Annual Free Cash Flow | $-2.1B |
| Market Cap | $25.3B |
Moderna, Inc.'s FCF yield of -8.2% is below the Healthcare sector average (4.9%).
Frequently Asked Questions
What is Moderna, Inc.'s (MRNA) free cash flow yield?
Moderna, Inc.'s (MRNA) free cash flow yield is -8.2%. That is below the Healthcare sector average (4.9%).
Is MRNA's free cash flow yield good?
At -8.2%, MRNA's free cash flow yield is considered weak — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Moderna, Inc. generate?
Moderna, Inc. generated $-2.1B in free cash flow, against a market cap of $25.3B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →